The University Of Texas MD Anderson Cancer Center IRB

FDA Regulatory Profile

The University Of Texas MD Anderson Cancer Center IRB has 0 FDA recalls, 3 inspections, 0 510(k) clearances and 0 compliance actions on record.

Latest inspection
Dec 12, 2024 · NAI

Reviewing The University Of Texas MD Anderson Cancer Center IRB as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Request a free FDA snapshot

Or get The University Of Texas MD Anderson Cancer Center IRB's full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Oct 23, 2026Not statedCurrent
510(k) clearances0Oct 4, 2026Not statedCurrent
Inspections3Oct 26, 2026Not statedCurrent
Compliance actions0Oct 23, 2026Not statedCurrent

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
University Of Texas Md Anderson Cancer Center
Same company group
00280—
University Of Texas, Md Anderson Cancer Center
Same company group
0100—

Recent FDA Inspections

DateSiteProductClassificationFEI
Dec 12, 2024Houston, TXDevicesNo Action Indicated (NAI)1626261
Mar 12, 2019Houston, TXDrugsNo Action Indicated (NAI)1626261
Aug 19, 2010Houston, TXBiologicsNo Action Indicated (NAI)1626261

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.